Klebsiella oxytoca enterotoxins tilimycin and tilivalline have distinct host DNA-damaging and microtubule-stabilizing activities

10 p.-6 fig.
Establishing causal links between bacterial metabolites and human intestinal disease is a significant challenge. This study reveals the molecular basis of antibiotic-associated hemorrhagic colitis (AAHC) caused by intestinal resident Klebsiella oxytoca Colitogenic strains produce the nonribosomal peptides tilivalline and tilimycin. Here, we verify that these enterotoxins are present in the human intestine during active colitis and determine their concentrations in a murine disease model. Although both toxins share a pyrrolobenzodiazepine structure, they have distinct molecular targets. Tilimycin acts as a genotoxin. Its interaction with DNA activates damage repair mechanisms in cultured cells and causes DNA strand breakage and an increased lesion burden in cecal enterocytes of colonized mice. In contrast, tilivalline binds tubulin and stabilizes microtubules leading to mitotic arrest. To our knowledge, this activity is unique for microbiota-derived metabolites of the human intestine. The capacity of both toxins to induce apoptosis in intestinal epithelial cells-a hallmark feature of AAHC-by independent modes of action, strengthens our proposal that these metabolites act collectively in the pathogenicity of colitis.
We acknowledge networking contributions from European Cooperation in Science and Technology Action CM1407, “Challenging Organic Syntheses Inspired by Nature—From Natural Products Chemistry to Drug Discovery.” Research was funded by the Austrian Science Fund W901 Doktoratskolleg Molecular Enzymology (to E.L.Z., S.S., W.K., and R.B.), BioTechMed-Graz Secretome Flagship (to S.S., E.L.Z., G.G., C.H., and R.B.), and Grant BFU2016-75319-R (Agencia Española de Investigacion/Fondo Europeo de desarrollo regional, Unión Europea) (to J.F.D.) from Ministerio de Economica y Competitividad.